Skip to main content
HR 4638 115th Congress House Health Advisory bodies Congressional oversight Government studies and investigations Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Musculoskeletal and skin diseases Organ and tissue donation and transplantation Research administration and funding Research and development

National Commission on Scleroderma and Fibrotic Diseases Act of 2017

Introduced: December 13, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 15, 2017
Referred to the Subcommittee on Health.
Dec 13, 2017
Referred to the House Committee on Energy and Commerce.
Dec 13, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Commission on Scleroderma and Fibrotic Diseases Act of 2017

This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

What's happening now December 15, 2017

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 3267 Related bill National Commission on Scleroderma and Fibrotic Diseases Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 20
All 20 Democratic 12 Republican 2
D
Beatty, Joyce
Ohio · Nov 16, 2018
BRADY, ROBERT
· Oct 30, 2018
 R
Fitzpatrick, Brian K.
Pennsylvania · Oct 30, 2018
ROS-LEHTINEN, ILEANA
· Oct 12, 2018
 D
Torres, Norma J.
California · Apr 18, 2018
Donovan, Daniel
· Apr 12, 2018
 D
Tonko, Paul
New York · Apr 11, 2018
CROWLEY, JOSEPH
· Mar 14, 2018
 D
Espaillat, Adriano
New York · Mar 14, 2018
 D
Meng, Grace
New York · Mar 14, 2018
 D
Nadler, Jerrold
New York · Mar 14, 2018
 D
Velázquez, Nydia M.
New York · Mar 14, 2018
Comstock, Barbara
· Dec 13, 2017
Delaney, John
· Dec 13, 2017
 D
Jayapal, Pramila
Washington · Dec 13, 2017
 D
McGovern, James P.
Massachusetts · Dec 13, 2017
 D
Norton, Eleanor Holmes
District of Columbia · Dec 13, 2017
 D
Pingree, Chellie
Maine · Dec 13, 2017
 D
Schiff, Adam B.
California · Dec 13, 2017
 R
Wagner, Ann
Missouri · Dec 13, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4638: National Commission on Scleroderma and Fibrotic Diseases Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4638/
MLA
"H.R. 4638: National Commission on Scleroderma and Fibrotic Diseases Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4638/.
Bluebook (legal)
H.R. 4638, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4638/.
Markdown link
[H.R. 4638: National Commission on Scleroderma and Fibrotic Diseases Act of 2017](https://openamerica.io/bill/115-HR-4638/)
Report a problem